Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Intrathecal SNX-111 for acute postoperative pain

April 30, 1998

Dopaminergic compound CI-1007 evaluated in schizophrenic patients

April 30, 1998

Patient dosing begins in trial of Allelix's selective serotonin agonist

April 30, 1998

Another series of substance P antagonists discovered at Pfizer

April 30, 1998

ABT-431, an improved therapeutic option for PD

April 30, 1998

Roche describes new agents for neurodegenerative disorders

April 30, 1998

Nicotinic agonist shown effective in primate model of PD

April 29, 1998

Treatment of neuropathic pain with gabapentin

April 29, 1998

Org-9487, a new short-acting neuromuscular blocker from Organon

April 29, 1998

Stanford gene therapy eases multiple sclerosis symptoms in mice

April 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...